Form 4: Arteris Director Sells Shares Under 10b5-1 Plan

Arteris, Inc. Director Raman Chitkara reported a sale of 5,000 shares of common stock for $25.0579 per share, executed under a pre-established 10b5-1 trading plan.

Summary

• Director Raman Chitkara sold 5,000 shares of Arteris, Inc. common stock.
• The transaction occurred on April 24, 2026.
• The weighted average sale price was $25.0579 per share, with individual sales ranging from $25.00 to $25.25.
• This sale was conducted under a Rule 10b5-1 trading plan adopted on March 7, 2025.
• Following the transaction, Chitkara beneficially owns 147,867 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While an insider sale can sometimes be perceived negatively, the transaction was conducted under a pre-arranged 10b5-1 plan, mitigating concerns about immediate negative sentiment.

Negatives

• Director Raman Chitkara sold a significant number of shares (5,000), which could be perceived negatively by the market.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider sales, particularly under 10b5-1 plans, are common for executives and directors to diversify holdings or manage personal finances. While this specific transaction is a sale, the use of a 10b5-1 plan suggests it was pre-planned and not necessarily a reflection of negative sentiment towards the company's future prospects.

Stakeholder Impact

• Shareholders may view the sale by a director with caution, although the 10b5-1 plan mitigates immediate negative interpretation.
• The company's management team and board of directors are indirectly impacted by the perception of insider transactions.

Key Dates

Keywords

Arteris, Inc., Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Director Transaction, Beneficial Ownership